© 2021 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Pharmacy
Express Scripts’ Formulary Management Process
September 15, 2021
Clinical appropriateness, not the cost of a drug, is the first consideration in formulary decisions, said Katie Thompson and Katie Deckelbaum of Express Scripts.
The Connection Between Telehealth, Pharmacy and How it Affects Self-Funded Employers
August 05, 2021
Managed Healthcare Executive had a conversation with Kelly Chillingworth, RPh, director of business development at RxBenefits this week about the unique connection between pharmacy and telemedicine, what impact telemedicine & its pharmacy costs have on self-funded employers and how the right virtual care services a health provider offers to their members can be essential to building a competitive benefit.
The Benefits of the Retail Drug Market and Why, When Civica RX Will be Taking Steps Further
June 22, 2021
In this part three video series, Civica Rx CEO Martin VanTrieste says Civica is launching an outpatient retail market with its first retail drug coming to the market next year.
2021 Managed Healthcare Executive® Pharmacy Survey: What Federal Policy Will Most Likely Occur in 2021, Which Will Curb Drug Prices?
June 17, 2021
In this final part of the MHE 2021 Pharmacy Survey, participants share their thoughts on which federal policies they favor as a way to curb drug prices and which policy is more likely to occur this year. MHE's annual pharmacy survey had over 225 respondents.
2021 Managed Healthcare Executive® Pharmacy Survey: Drugs New to the Market Most Likely to Reduce Morbidity, Mortality
June 16, 2021
In this part five series, participants give their opinions on which drugs newer to the market in the last 12 months hold the most promise to reducing morbidity and mortality. Participants also shared which drug in the pipeline holds the most promise. MHE's annual pharmacy survey had over 225 respondents. We will be posting the results over the next few days.
2021 Managed Healthcare Executive® Pharmacy Survey: Biggest Driver in Specialty Drugs, Contract Changes Between Plan Sponsors and PBMs
June 14, 2021
In this part four series, participants give their opinions on the biggest driver of specialty drug expenditures this year and what the most significant change in contracts between plan sponsors and PBMs could be in the near future. MHE's annual pharmacy survey had over 225 respondents. We will be posting the results over the next few days.
2021 Managed Healthcare Executive® Pharmacy Survey: Most Effective Ways to Reduce Pharmaceutical Costs
June 12, 2021
In this part three series, participants give their opinions on the most effective ways to reduce traditional and specialty pharmaceutical costs. MHE's annual pharmacy survey had over 225 respondents. We will be posting the results over the next several days.
Results from 2021 Managed Healthcare Executive® Pharmacy Survey
June 10, 2021
Respondents upbeat about COVID-19 vaccination. MHE's annual pharmacy survey had over 225 respondents. We will be posting the results over the next several days.
Specialty Exceeds Traditional in Drug Spend
June 07, 2021
Ten years ago, specialty accounted for 15% to 20% of the money spent on drugs, according to Prem Shah, executive vice president of specialty pharmacy and product innovation at CVS Health.
Healthcare Leaders Say Lack of Communication Between Prescribers, Pharmacists is Biggest Issue in Medication Management
May 24, 2021
Two of the biggest issues in healthcare, currently, are the lack of communication between prescribers and pharmacists, and the number of factors that prevent healthcare professionals from offering patient-centric services.